Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Wróbel

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
The Journal of Investigative Dermatology|January 25, 2003
Differentiation and apoptosis in human immortalized sebocytesAnna Wróbel, Holger Seltmann, Sabine Fimmel, et al.
Oncotarget|April 20, 2017
SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domainsTomasz Rzymski, Michał Mikula, Eliza Żyłkiewicz, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
The Journal of Investigative Dermatology|January 25, 2003
Differentiation and apoptosis in human immortalized sebocytesAnna Wróbel, Holger Seltmann, Sabine Fimmel, et al.
Oncotarget|April 20, 2017
SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domainsTomasz Rzymski, Michał Mikula, Eliza Żyłkiewicz, et al.
Pageof 4